Streetbeat News

Products Services

LUCD

Lucid Diagnostics announced data from the ESOGUARD BE-1 study, showing 87.5% sensitivity and 98.6% NPV for the EsoGuard test. This strengthens the clinical validity for Medicare LCD pre-submission and commercial payor engagements. Additionally, data from the Cleveland VA study has been accepted for peer-reviewed publication.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:56 am

XIACF

XIACY

Xiaomi EV, the car-making unit of Xiaomi Corp., is ramping up production to reduce waiting times for its Xiaomi SU7 model. The company has initiated double-shift production and aims to deliver over 100,000 units in 2024. Current orders face a 30-week delivery wait, but lead times are expected to reduce by up to five weeks.

Portfolio Pulse from Nabaparna Bhattacharya

July 02, 2024 | 11:48 am

SMEGF

Siemens Energy AG plans to hire over 10,000 new employees to boost its electricity grid business, aiming for significant growth over the next six years. The company is investing €1.2 billion in capital expenditures to expand manufacturing capacity in the U.S., Europe, and Asia.

Portfolio Pulse from Lekha Gupta

July 02, 2024 | 11:43 am

CGTX

Cognition Therapeutics will present the Phase 2 SHINE study of CT1812, a treatment for mild-to-moderate Alzheimer's disease, at the Alzheimer's Association's International Conference.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:38 am

JNJ

Johnson & Johnson's second interim analysis of the Phase 3 Cartitude-4 study of Carvykti versus standard therapies for relapsed or lenalidomide-refractory multiple myeloma shows statistically significant and clinically meaningful improvement in overall survival.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:37 am

STRM

Streamline Health has secured a new contract for its eValuator solution with a 750-bed academic medical center in Texas. This contract is expected to enhance the hospital's revenue cycle management.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:36 am

MRNA

Moderna has received a $176 million award from the Rapid Response Partnership Vehicle to advance the development of mRNA-based pandemic influenza vaccines.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:33 am

AMD

NVDA

PARA

QQQ

SPY

TSLA

US stocks are set for a lower start as traders await key data and speeches, including Tesla's Q2 data and Fed Chair Powell's speech. The Nasdaq Composite closed at a record high, but futures indicate a downturn. Tesla, Nvidia, AMD, and Paramount Global are in focus.

Portfolio Pulse from Shanthi Rexaline

July 02, 2024 | 11:28 am

BTCUSD

USDCUSD

A report by 10x Research explores the recent 4% surge in Bitcoin's price, potentially linked to former President Donald Trump's strong position in the 2024 election race. The report suggests that while Bitcoin could see short-term gains, a drop to $55,000 is possible in the coming weeks. Seasonal trends, technical indicators, and challenges faced by Bitcoin mining companies are also discussed. Increased exchange balances and outflows from Circle's USDC indicate potential selling pressure.

Portfolio Pulse from Murtuza Merchant

July 02, 2024 | 11:22 am

TSN

Tyson Foods is reducing its antibiotic-free beef offerings, following a similar move with its chicken products.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 11:19 am